Krystal Biotech KRYS
NASDAQ KRYS
$335.06 -2.02 (-0.60%)
At close: Sep 29, 2026 · 4:00 PM EDT

Krystal Biotech (KRYS) Total Current Liabilities (2016 - 2026)

Updated

Krystal Biotech (KRYS) posted Total Current Liabilities of $127.4 million for Q2 2026, up 46.6% from $86.9 million a year earlier and up 18.2% from the prior quarter.

Analysis

Krystal Biotech (KRYS) Total Current Liabilities (2016 - 2026) Analysis & Trends

At the end of FY2025, Krystal Biotech's Total Current Liabilities came in at $102.94 million, up 0.9% from FY2024.

  • Annual Total Current Liabilities has increased for eight consecutive years, with a five-year compound annual growth rate of 46.1% (FY2020 to FY2025).
  • In prior years, Krystal Biotech's Total Current Liabilities was $102 million in FY2024 (+208.2%), $33.09 million in FY2023 (+14.7%), $28.85 million in FY2022 (+12.1%) and $25.74 million in FY2021 (+66.6%).
  • The Q2 2026 figure stands as the highest quarterly Total Current Liabilities in data going back to Q4 2016.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last 11 quarters, with growth averaging 75.7% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q1 2022, with growth of 560.9%; the weakest was Q1 2023, with a decline of 42.0%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $107.8 million (Q1 2026), $102.94 million (Q4 2025) and $91.27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Krystal Biotech 9.98 Bn 6.75 Bn 112.79 Mn 127.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 127.40 Mn
Mar 31, 2026 107.80 Mn
Dec 31, 2025 102.94 Mn
Sep 30, 2025 91.27 Mn
Jun 30, 2025 86.90 Mn
Mar 31, 2025 79.49 Mn
Dec 31, 2024 102.00 Mn
Sep 30, 2024 89.53 Mn
Jun 30, 2024 71.85 Mn
Mar 31, 2024 47.59 Mn
Dec 31, 2023 33.09 Mn
Sep 30, 2023 27.58 Mn
Jun 30, 2023 23.90 Mn
Mar 31, 2023 35.08 Mn
Dec 31, 2022 28.85 Mn
Sep 30, 2022 28.03 Mn
Jun 30, 2022 34.43 Mn
Mar 31, 2022 60.44 Mn
Dec 31, 2021 25.74 Mn
Sep 30, 2021 35.78 Mn
API Access

Krystal Biotech Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=KRYS&period=max&api_key=YOUR_API_KEY